Analysis and discussion of industries, products, patents, industrial inventiveness, and biomedical research. Ethical issues associated with research, introduction of new products, animal subjects, and human subjects.
As part of the continuous assessment and improvement process associated with accreditation of the Biomedical Engineering Program by the Accreditation Board for Engineering and Technology (ABET), faculty within the program have undertaken a comprehensive review and revision of the undergraduate curriculum and approved (September 28, 2016) several course changes. These changes, which are based upon input from senior course reviews and exit interviews, include modifications to the sequencing of coursework, course pre- and co-requisites, learning outcomes, and course descriptions.
Within the revised curriculum, the content of BMEN 101 will be augmented, leading to an increase in the credit hours for BMEN 101 and removal of BMEN 202 from curriculum requirements as well as a change in the title for BMEN 101. In parallel, the pre-requisite for BMEN 303 has been changed from BMEN 202 to BMEN 101, and the title for BMEN 303 has also changed as this course is no longer the thrid in a series.
In addition, the BMEN 303 learning outcome pertaining to speech has been removed. This learning outcome was added when the course was undergoing consideration for the speech requirement within Carolina Core. Since that time, however, the undergraduate committee has decided instead to require students to take a different university-approved course to satisfy the Carolina Core speech requirement. Thus, the speech content of BMEN 303 will be reduced to allow the couse to cover a wider variey of professional development topics. The catalog description and learning outcomes have been modified accordingly.
Thank you for submitting your proposal to the Committee on Curricula & Courses. We appreciate your patience and commitment to undergraduate and graduate education.